Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Originally published in Science Express on 4 December 2008
Science 19 December 2008:
Vol. 322. no. 5909, pp. 1839 - 1842
DOI: 10.1126/science.1165409
Prev | Table of Contents | Next

Reports

Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A

Vijay G. Sankaran,1,2 Tobias F. Menne,1 Jian Xu,1 Thomas E. Akie,1 Guillaume Lettre,3,4 Ben Van Handel,5 Hanna K. A. Mikkola,5 Joel N. Hirschhorn,3,4 Alan B. Cantor,1 Stuart H. Orkin1,2,6*

Differences in the amount of fetal hemoglobin (HbF) that persists into adulthood affect the severity of sickle cell disease and the β-thalassemia syndromes. Genetic association studies have identified sequence variants in the gene BCL11A that influence HbF levels. Here, we examine BCL11A as a potential regulator of HbF expression. The high-HbF BCL11A genotype is associated with reduced BCL11A expression. Moreover, abundant expression of full-length forms of BCL11A is developmentally restricted to adult erythroid cells. Down-regulation of BCL11A expression in primary adult erythroid cells leads to robust HbF expression. Consistent with a direct role of BCL11A in globin gene regulation, we find that BCL11A occupies several discrete sites in the β-globin gene cluster. BCL11A emerges as a therapeutic target for reactivation of HbF in β-hemoglobin disorders.

1 Division of Hematology/Oncology, Children's Hospital Boston, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA 02115, USA.
2 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
3 Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
4 Divisions of Genetics and Endocrinology and Program in Genomics, Children's Hospital Boston, Boston, MA 02115, USA.
5 Department of Molecular, Cell, and Developmental Biology, University of California at Los Angeles, Los Angeles, CA 90095, USA.
6 Howard Hughes Medical Institute, Boston, MA 02115, USA.

* To whom correspondence should be addressed. E-mail: stuart_orkin{at}dfci.harvard.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression.
G. Rank, L. Cerruti, R. J. Simpson, R. L. Moritz, S. M. Jane, and Q. Zhao (2010)
Blood 116, 1585-1592
   Abstract »    Full Text »    PDF »
Pulmonary hypertension and nitric oxide depletion in sickle cell disease.
H. F. Bunn, D. G. Nathan, G. J. Dover, R. P. Hebbel, O. S. Platt, W. F. Rosse, and R. E. Ware (2010)
Blood 116, 687-692
   Abstract »    Full Text »    PDF »
Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex.
M. Gabbianelli, U. Testa, O. Morsilli, E. Pelosi, E. Saulle, E. Petrucci, G. Castelli, S. Giovinazzi, G. Mariani, M. E. Fiori, et al. (2010)
Haematologica 95, 1253-1260
   Abstract »    Full Text »    PDF »
Long-range function of an intergenic retrotransposon.
W. Pi, X. Zhu, M. Wu, Y. Wang, S. Fulzele, A. Eroglu, J. Ling, and D. Tuan (2010)
PNAS 107, 12992-12997
   Abstract »    Full Text »    PDF »
Sickle Cell Disease at 100 Years.
S. H. Orkin and D. R. Higgs (2010)
Science 329, 291-292
   Abstract »    Full Text »    PDF »
Role of the GATA-1/FOG-1/NuRD Pathway in the Expression of Human {beta}-Like Globin Genes.
A. Miccio and G. A. Blobel (2010)
Mol. Cell. Biol. 30, 3460-3470
   Abstract »    Full Text »    PDF »
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.
J. E. Bradner, R. Mak, S. K. Tanguturi, R. Mazitschek, S. J. Haggarty, K. Ross, C. Y. Chang, J. Bosco, N. West, E. Morse, et al. (2010)
PNAS 107, 12617-12622
   Abstract »    Full Text »    PDF »
Transcriptional silencing of {gamma}-globin by BCL11A involves long-range interactions and cooperation with SOX6.
J. Xu, V. G. Sankaran, M. Ni, T. F. Menne, R. V. Puram, W. Kim, and S. H. Orkin (2010)
Genes & Dev. 24, 783-798
   Abstract »    Full Text »    PDF »
A zinc-finger transcriptional activator designed to interact with the {gamma}-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts.
A. Wilber, U. Tschulena, P. W. Hargrove, Y. S. Kim, D. A. Persons, C. F. Barbas III, and A. W. Nienhuis (2010)
Blood 115, 3033-3041
   Abstract »    Full Text »    PDF »
Developmental Silencing of Human {zeta}-Globin Gene Expression Is Mediated by the Transcriptional Repressor RREB1.
R.-L. Chen, Y.-C. Chou, Y.-J. Lan, T.-S. Huang, and C.-K. J. Shen (2010)
J. Biol. Chem. 285, 10189-10197
   Abstract »    Full Text »    PDF »
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene cluster.
N. Solovieff, J. N. Milton, S. W. Hartley, R. Sherva, P. Sebastiani, D. A. Dworkis, E. S. Klings, L. A. Farrer, M. E. Garrett, A. Ashley-Koch, et al. (2010)
Blood 115, 1815-1822
   Abstract »    Full Text »    PDF »
Mta3-NuRD complex is a master regulator for initiation of primitive hematopoiesis in vertebrate embryos.
X. Li, S. Jia, S. Wang, Y. Wang, and A. Meng (2009)
Blood 114, 5464-5472
   Abstract »    Full Text »    PDF »
Sickle cell disease and stroke.
L. A. Verduzco and D. G. Nathan (2009)
Blood 114, 5117-5125
   Abstract »    Full Text »    PDF »
Amelioration of Sardinian {beta}0 thalassemia by genetic modifiers.
R. Galanello, S. Sanna, L. Perseu, M. C. Sollaino, S. Satta, M. E. Lai, S. Barella, M. Uda, G. Usala, G. R. Abecasis, et al. (2009)
Blood 114, 3935-3937
   Abstract »    Full Text »    PDF »
Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.
S. L. Thein, S. Menzel, M. Lathrop, and C. Garner (2009)
Hum. Mol. Genet. 18, R216-R223
   Abstract »    Full Text »    PDF »
Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.
O. Sripichai, C. M. Kiefer, N. V. Bhanu, T. Tanno, S.-J. Noh, S.-H. Goh, J. E. Russell, C. L. Rognerud, C.-N. Ou, P. A. Oneal, et al. (2009)
Blood 114, 2299-2306
   Abstract »    Full Text »    PDF »
Regulation of Fetal Hemoglobin Expression.
(2009)
Journal Watch Oncology and Hematology 2009, 2
   Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)